Biomarin Pharmaceutical (BMRN) Return on Capital Employed: 2009-2025
Historic Return on Capital Employed for Biomarin Pharmaceutical (BMRN) over the last 14 years, with Sep 2025 value amounting to 0.09%.
- Biomarin Pharmaceutical's Return on Capital Employed rose 4.00% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 4.00%. This contributed to the annual value of 0.08% for FY2024, which is 4.00% up from last year.
- As of Q3 2025, Biomarin Pharmaceutical's Return on Capital Employed stood at 0.09%, which was down 22.10% from 0.12% recorded in Q2 2025.
- In the past 5 years, Biomarin Pharmaceutical's Return on Capital Employed registered a high of 0.12% during Q2 2025, and its lowest value of -0.02% during Q1 2021.
- In the last 3 years, Biomarin Pharmaceutical's Return on Capital Employed had a median value of 0.05% in 2024 and averaged 0.06%.
- Its Return on Capital Employed has fluctuated over the past 5 years, first decreased by 4bps in 2021, then climbed by 7bps in 2025.
- Biomarin Pharmaceutical's Return on Capital Employed (Quarterly) stood at -0.02% in 2021, then increased by 4bps to 0.03% in 2022, then remained steady at 0.03% in 2023, then grew by 4bps to 0.08% in 2024, then climbed by 4bps to 0.09% in 2025.
- Its last three reported values are 0.09% in Q3 2025, 0.12% for Q2 2025, and 0.10% during Q1 2025.